519
Participants
Start Date
July 25, 2014
Primary Completion Date
June 20, 2017
Study Completion Date
November 28, 2017
Peficitinib
oral tablet
Placebo
oral tablet
Methotrexate
Oral tablet/capsule
JP00037, Nagoya
JP00109, Nagoya
JP00130, Nagoya
JP00175, Nagoya
JP00066, Okazaki
JP00108, Toyohashi
JP00170, Toyohashi
JP00156, Toyota
JP00068, Yatomi
JP00180, Asahi
JP00166, Funabashi
JP00115, Narashino
JP00138, Yotsukaidō
JP00120, Iizuka
JP00110, Kasuga
JP00040, Kitakyushu
JP00119, Kitakyushu
JP00071, Kurume
JP00106, Kurume
JP00033, Takasaki
JP00163, Higashihiroshima
JP00124, Tomakomai
JP00026, Asahikawa
JP00090, Hakodate
JP00172, Kitami
JP00125, Kushiro
JP00001, Sapporo
JP00002, Sapporo
JP00003, Sapporo
JP00038, Sapporo
JP00114, Sapporo
JP00056, Akashi
JP00069, Himeji
JP00136, Itami
JP00113, Kakogawa
JP00041, Katō
JP00042, Kobe
JP00092, Kobe
JP00154, Kobe
JP00171, Kobe
JP00117, Nishinomiya
JP00107, Hitachi
JP00181, Hitachi-Naka
JP00073, Koga
JP00054, Mito
JP00039, Tsukuba
JP00179, Komatsu
JP00049, Morioka
JP00088, Kida
JP00084, Isehara
JP00048, Kawasaki
JP00058, Kawasaki
JP00141, Sagamihara
JP00096, Yokohama
JP00045, Zushi
JP00019, Kōshi
JP00057, Tamana
JP00168, Yokkaichi
JP00169, Ōsaki
JP00004, Sendai
JP00036, Sendai
JP00105, Sendai
JP00151, Sendai
JP00050, Hyūga
JP00129, Matsumoto
JP00162, Isehaya
JP00101, Ōmura
JP00103, Ōmura
JP00153, Sasebo
JP00094, Kashihara
JP00025, Nagaoka
JP00144, Shibata
JP00064, Beppu
JP00051, Setouchi
JP00011, Hannan
JP00134, Higashiosaka
JP00178, Hirakata
JP00078, Kawachi-Nagano
JP00137, Sakai
JP00070, Suita
JP00146, Suita
JP00061, Toyonaka
JP00075, Ureshino
JP00126, Gyōda
JP00007, Hiki
JP00060, Kawagoe
JP00161, Kawagoe
JP00062, Kawaguchi
JP00052, Sayama
JP00008, Tokorozawa
JP00133, Kakegawa
JP00077, Kanuma
JP00145, Shimotsuke
JP00024, Bunkyo
JP00143, Bunkyo
JP00149, Bunkyo
JP00152, Bunkyo
JP00099, Chiyoda City
JP00142, Chūō
JP00063, Hachiōji
JP00053, Kiyose
JP00072, Meguro City
JP00148, Ōta-ku
JP00081, Shibuya City
JP00010, Takaoka
JP00155, Nishimuro
JP00104, Shimonoseki
JP00047, Shūnan
JP00176, Fukui
JP00018, Fukuoka
JP00020, Fukuoka
JP00035, Fukuoka
JP00059, Fukuoka
JP00067, Fukuoka
JP00076, Fukuoka
JP00131, Fukuoka
JP00164, Fukuoka
JP00165, Fukushima
JP00013, Hiroshima
JP00014, Hiroshima
JP00016, Hiroshima
JP00055, Hiroshima
JP00074, Kagoshima
JP00167, Kagoshima
JP00093, Kochi
JP00022, Kumamoto
JP00046, Kumamoto
JP00085, Kyoto
JP00123, Kyoto
JP00160, Kyoto
JP00023, Miyagi
JP00122, Miyazaki
JP00080, Nagano
JP00174, Nagano
JP00098, Nagasaki
JP00112, Nagasaki
JP00147, Nagasaki
JP00118, Okayama
JP00150, Osaka
JP00157, Osaka
JP00177, Osaka
JP00017, Ōita
JP00044, Shizuoka
JP00089, Shizuoka
JP00135, Shizuoka
JP00139, Toyama
Lead Sponsor
Astellas Pharma Inc
INDUSTRY